LV10083B - Method of preparation of (6s)- and (6r)-tetrahydrofolic acid - Google Patents

Method of preparation of (6s)- and (6r)-tetrahydrofolic acid Download PDF

Info

Publication number
LV10083B
LV10083B LVP-93-220A LV930220A LV10083B LV 10083 B LV10083 B LV 10083B LV 930220 A LV930220 A LV 930220A LV 10083 B LV10083 B LV 10083B
Authority
LV
Latvia
Prior art keywords
acid
tetrahydrofolic
τγφκ
sulphonic
kmcjlotbl
Prior art date
Application number
LVP-93-220A
Other languages
English (en)
Latvian (lv)
Other versions
LV10083A (lv
Inventor
Hans Rudolf M Ller
Martin Ulmann
Josef Conti
G Nter M Rdel
Original Assignee
Eprova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eprova Ag filed Critical Eprova Ag
Publication of LV10083A publication Critical patent/LV10083A/xx
Publication of LV10083B publication Critical patent/LV10083B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
LVP-93-220A 1991-01-16 1993-04-02 Method of preparation of (6s)- and (6r)-tetrahydrofolic acid LV10083B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH108/91A CH681303A5 (hu) 1991-01-16 1991-01-16

Publications (2)

Publication Number Publication Date
LV10083A LV10083A (lv) 1994-05-10
LV10083B true LV10083B (en) 1995-04-20

Family

ID=4179454

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-220A LV10083B (en) 1991-01-16 1993-04-02 Method of preparation of (6s)- and (6r)-tetrahydrofolic acid

Country Status (25)

Country Link
US (1) US5324836A (hu)
EP (1) EP0495204B1 (hu)
JP (1) JPH0739417B2 (hu)
KR (1) KR100207133B1 (hu)
CN (1) CN1030079C (hu)
AT (1) ATE123777T1 (hu)
AU (1) AU654993B2 (hu)
CA (1) CA2059103C (hu)
CH (1) CH681303A5 (hu)
DE (1) DE59105722D1 (hu)
DK (1) DK0495204T3 (hu)
ES (1) ES2075315T3 (hu)
FI (1) FI109906B (hu)
GE (1) GEP19971019B (hu)
HU (1) HU207083B (hu)
IE (1) IE72164B1 (hu)
IL (1) IL100478A (hu)
LV (1) LV10083B (hu)
MX (1) MX9200063A (hu)
NO (1) NO301422B1 (hu)
NZ (1) NZ241245A (hu)
PT (1) PT100014B (hu)
RU (1) RU2099340C1 (hu)
TW (1) TW198033B (hu)
ZA (1) ZA92291B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682664A5 (en) * 1991-10-15 1993-10-29 Eprova Ag Stable salts of 5,10-methylene tetrahydrofolate.
DE4136921A1 (de) * 1991-11-11 1993-05-13 Knoll Ag Verfahren zur trennung von 5-methyl-tetrahydrofolsaeure
CH683262A5 (it) * 1992-01-22 1994-02-15 Applied Pharma Res Procedimento per la separazione dei diastereomeri del sale di calcio dell'acido (6(R,S)-N-formiltetraidrofolico).
IT1254635B (it) * 1992-02-20 1995-09-28 Bracco Spa Processo per la separazione degli stereoisomeri dell'acido folinico
CH684644A5 (de) * 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
CH686672A5 (de) * 1992-12-01 1996-05-31 Cerbios Pharma Sa Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.
CH686369A5 (de) * 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
CH689831A5 (de) * 1995-11-07 1999-12-15 Eprova Ag Stabile kristalline Tetrahydrofolsaeure-Salze.
CH693905A5 (de) 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH694251A5 (de) * 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
CH695217A5 (de) * 1999-07-14 2006-01-31 Merck Eprova Ag Verfahren zur Trennung optischer Isomeren von Tetrahydrofolsäureestersalzen und Tetrahydrofolsäure.
NZ527033A (en) 2001-01-16 2005-04-29 Berkshire Lab Inc Enhanced data storage and retrieval devices and systems and methods by optical means or by utilising a stored magnetic field strength to cause an amount of shifting of at least one frequency
ITMI20020132A1 (it) 2002-01-25 2003-07-25 Gmt Fine Chemicals Sa Processo per l'ottenimento dell'acido (6s)-5,6,7,8-tetraidrofolico
US7408729B2 (en) 2002-11-21 2008-08-05 Gr Intellectual Reserve, Llc Enhanced data storage and retrieval devices and systems and methods for utilizing same
CH696717A5 (de) * 2004-02-20 2007-10-31 Cerbios Pharma Sa Konzentrierte, stabile Losung, insbesondere eine Injektionslosung oder Infusionslosung, welche nebst Wasser entweder (6S)-Natrium-Folinat oder (6S)-Kalium-Folinat entholt
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
CN101407518A (zh) * 2007-10-11 2009-04-15 南京莱尔生物化工有限公司 (6r,s)-5-甲酰-四氢叶酸的拆分及其成盐的方法
CN104334561B (zh) 2012-04-13 2016-06-22 连云港金康和信药业有限公司 化合物jk12a及其制备
CN104045640B (zh) * 2013-03-14 2016-04-06 天津康鸿医药科技发展有限公司 一种制备高纯度左亚叶酸钙的方法
CN104774169B (zh) * 2014-01-15 2017-02-15 上海韶远试剂有限公司 一种利用非手性助剂进行非对映异构体拆分的新方法
CN108164531B (zh) * 2018-02-12 2019-11-05 江苏红豆杉药业有限公司 一种l-5-甲基四氢叶酸钙的制备方法
CN112351818A (zh) 2018-07-06 2021-02-09 默克专利股份有限公司 5-甲基-(6s)-四氢叶酸和l-异亮氨酸乙酯的结晶盐

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468886A (en) * 1967-10-23 1969-09-23 Us Health Education & Welfare Tetrahydrohomofolic acid sulfate and synthesis thereof
DE2063027A1 (de) * 1969-12-26 1971-07-01 Yamanouchi Pharmaceutical Co Ltd , Tokio Salz einer basischen Aminosäure der 5 6,7,8 Tetrahydrofolsaure
JPS4832120A (hu) * 1971-08-31 1973-04-27
US4665176A (en) * 1984-10-23 1987-05-12 Mitsui Toatsu Chemicals, Incorporated Process for the preparation of 5,6,7,8-tetrahydrofolic acid
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
CH673459A5 (hu) * 1987-05-15 1990-03-15 Eprova Ag
DE3821875C1 (hu) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
JPH0265787A (ja) * 1988-08-30 1990-03-06 Kyowa Hakko Kogyo Co Ltd Ｌ（‐）‐テトラヒドロ葉酸の製造法
CH676981A5 (hu) * 1988-11-11 1991-03-28 Eprova Ag
FR2643081B1 (fr) * 1989-02-14 1991-06-07 Panmedica Sa Folates de magnesium, procede de preparation et compositions pharmaceutiques
US5173488A (en) * 1989-08-21 1992-12-22 American Cyanamid Company Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
DE69027585T2 (de) * 1989-12-11 1997-01-16 American Cyanamid Co Verfahren zur Herstellung von optisch reinen Diastereoisomeren von Tetrahydrofolatverbindungen
CH680731A5 (hu) * 1990-04-12 1992-10-30 Sapec Fine Chemicals

Also Published As

Publication number Publication date
TW198033B (hu) 1993-01-11
CN1063285A (zh) 1992-08-05
HUT60272A (en) 1992-08-28
ZA92291B (en) 1992-09-30
MX9200063A (es) 1993-01-01
PT100014B (pt) 1999-08-31
FI920180A0 (fi) 1992-01-15
EP0495204B1 (de) 1995-06-14
KR920014812A (ko) 1992-08-25
DE59105722D1 (de) 1995-07-20
CN1030079C (zh) 1995-10-18
CH681303A5 (hu) 1993-02-26
IE920112A1 (en) 1992-07-29
AU654993B2 (en) 1994-12-01
IL100478A0 (en) 1992-09-06
US5324836A (en) 1994-06-28
NO920197D0 (no) 1992-01-15
KR100207133B1 (ko) 1999-07-15
FI920180A (fi) 1992-07-17
HU9200134D0 (en) 1992-04-28
NO301422B1 (no) 1997-10-27
IL100478A (en) 1999-03-12
HU207083B (en) 1993-03-01
ES2075315T3 (es) 1995-10-01
LV10083A (lv) 1994-05-10
NO920197L (no) 1992-07-17
JPH04312586A (ja) 1992-11-04
JPH0739417B2 (ja) 1995-05-01
DK0495204T3 (da) 1995-08-07
CA2059103C (en) 1996-12-17
IE72164B1 (en) 1997-03-26
AU1025492A (en) 1992-07-23
RU2099340C1 (ru) 1997-12-20
EP0495204A1 (de) 1992-07-22
FI109906B (fi) 2002-10-31
CA2059103A1 (en) 1992-07-17
GEP19971019B (en) 1997-05-22
NZ241245A (en) 1993-11-25
PT100014A (pt) 1993-03-31
ATE123777T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
LV10083B (en) Method of preparation of (6s)- and (6r)-tetrahydrofolic acid
PL126606B1 (en) Method for producing (6r,7r)-7/(z)-2(2-aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido/-3-(1-pyridinium-methyl)-ceph-3-em-4-carboxylate
Kakiuchi et al. Ca2+-and calmodulin-dependent flip—flop mechanism in microtubule assembly—disassembly
EP1734039A1 (en) Aryl urea compounds as BETA-secretase inhibitors
US20060035899A1 (en) Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
SE8307119D0 (sv) Carboxylic acid amides and their derivatives
US4175125A (en) Method for treating methicillin resistant staphylococcus aureus
AU2018200421A1 (en) Naphthyridinedione derivatives
YU81392A (sr) Diasterreoizomeri 3-cefem-4karboksi-1-(izopropoksi karboniloksi)etil-estra i postupak za njihovu proizvodnju
CA1171849A (en) Penicillanoyloxymethyl penicillanate 1,1,1',1'- tetraoxide
US3459746A (en) 7 - heteromonocyclic-substituted acylamido derivatives of desacetyl cephalosporanic acid
JPS5724389A (en) Novel cephem compound, its preparation, and preventive and remedy for bacteriosis
US4061748A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
KAWAMOTO et al. Regulation of N‐Acetylglutamate Synthetase in Mouse Liver: Postprandial Changes in Sensitivity to Activaation by Arginine
US4117126A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
AU2003291282A1 (en) N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor
US3884915A (en) 7-Alkylmercaptoacetamido cephalosporins
US3907784A (en) 7-Halophenylthioacetamido cephalosporins
Kirk et al. IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death
CA1038759A (en) Mixtures of cephalosporin and penicillin type antibiotics
US3341532A (en) Substituted 7-acetylamino cephalosporanic acids
Randolph et al. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model
Umegaki et al. The appearance of “exhausted” platelets at the time of stroke in stroke-prone spontaneously hypertensive rats
GB1505525A (en) Pyridopyrimidines
EP0068403B1 (en) Cephalosporin compound